Merck’s covid antiviral drug molnupiravir a USELESS DUD, study finds

(Natural News) On December 22, The Lancet published a study showing that it is pointless to take Merck & Co.'s antiviral covid drug molnupiravir because it does nothing to prevent hospitalization or death in higher-risk vaccinated adults.The company claims the drug treats mild to moderate covid infection via twice-daily intake for … [Read More...]